跳至主要内容
临床试验/NCT06231420
NCT06231420Enrolling By Invitation不适用

Daily Step Count Using Pedometer for Sarcopenic Management in Patient With Cirrhosis: Randomized Controlled Trial

Mahidol University2 个研究点 分布在 1 个国家目标入组 70 人开始时间: 2024年2月1日最近更新:
适应症

试验速览

阶段
不适用
状态
Enrolling By Invitation
入组人数
70
试验地点
2
主要终点
To compare change of skeletal muscle index (SMI) between encourage using pedometer group and discourage using pedometer group.

研究概览

简要总结

The goal of clinical trial is to compare using pedometer in sarcopenic cirrhotic patients. The main questions it aims to answer are:

  1. Did the encourage using pedometer group had higher change of skeletal muscle index (SMI) than discourage using pedometer group?
  2. How many of patients who had sarcopenic improvement in both groups at 6 months after enrollment?
  3. What is the mortality rate and hospital admission in both groups at 12 months after enrollment?

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18 - 75 years old
  • Cirrhotic patient with diagnosed sarcopenia
  • Patients or caregiver who can write and announce Thai language
  • Cirrhotic patient who was post liver transplantation > 1 year

排除标准

  • Cirrhosis Child-Turcotte-Pugh (CTP) C > 10
  • Refractory ascites
  • Decompensated comorbidity: heart failure NYHA III-IV, ESRD with dialysis, COPD Gold D
  • Performance status ECOG 3-4
  • Bone fracture within 4 weeks or limitation of activity
  • Pregnancy and breastfeeding
  • HCC during treatment with TACE or microwave ablation or radiofrequency ablation within 6 months before enrollment
  • Advanced stage malignancy
  • Received chemotherapy
  • Muscle weakness disease
  • Recent cerebrovascular disease within 6 months and motor weakness grade < II
  • Age 65-75 years old with history of falling > 2 times/year

结局指标

主要结局

To compare change of skeletal muscle index (SMI) between encourage using pedometer group and discourage using pedometer group.

时间窗: 6 months

Change of skeletal muscle index (SMI) between both groups.

次要结局

  • The hospital admission(12 months)
  • Number of patients who improved sarcopenia in encourage using pedometer group and discourage using pedometer group.(6 months)
  • Mortality rate in encourage using pedometer group and discourage using pedometer group.(12 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Watcharasak Chotiyaputta

Associate professor, Faculty of Medicine Siriraj Hospital

Mahidol University

研究点 (2)

Loading locations...

相似试验

Daily Step Count Using Pedometer for Sarcopenic... | 临床试验